Therefore, we further explored the relevance of ARRDC2 to immune cells and immune checkpoints in the tumor immune microenvironment of ovarian cancer using the TIMER and TISIDB databases (Ru et al., 2019). Here, ARRDC2 is linked to ovarian carcinoma.